Are Small Cap stocks really overvalued?
- nishantuparikh
- Feb 15, 2025
- 3 min read
Updated: Feb 16, 2025

Recently, there has been a lot of chatter about the overvaluation in the small cap segment and subsequent correction that we have witnessed. During such times, it is very important to keep our emotions aside and look at the right data to make informed decisions.
While one can look at various metrics for valuations such as Price to Earning (PE) ratio, Price/earnings-to-growth (PEG) ratio, Price to Book (PB) ratio among others to analyze these stocks in detail, the most commonly used is PE ratio.
For the purposes of our analysis and simplicity, we shall look at the PE of the Nifty Smallcap 250 Index that encompasses the small cap universe to get a sense of how valuations are.
As depicted in the table below, we can see that as on 14th February 2025, we are at a value lower than the Median Value of last 5 years:
Metric | Current Value as on 14 Feb 2025 | Median Value of last 5 years |
Trailing PE for Nifty Smallcap250 | 27.5 | 28.9 |
Now, if we drill down further and look at each stock, one will see how the number is skewed on the higher side due to 18 specific stocks having PE of more than 100.
In fact, just the top 3 names in the list below with an average market capitalization of ~ INR 17,900 crores have an average PE of more than 1000.
Source: Screener.in
S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. |
1 | Devyani Intl. | 158 | 1424 | 19094 |
2 | A B Real Estate | 2069 | 1267 | 23106 |
3 | Westlife Food | 725 | 994 | 11306 |
4 | Piramal Pharma | 185 | 467 | 24513 |
5 | Sapphire Foods | 300 | 391 | 9622 |
6 | PTC Industries | 13083 | 381 | 19604 |
7 | Sterling & Wils. | 261 | 222 | 6085 |
8 | Sobha | 1161 | 204 | 12410 |
9 | SignatureGlobal | 1168 | 202 | 16411 |
10 | Chalet Hotels | 694 | 150 | 15151 |
11 | Laurus Labs | 546 | 147 | 29449 |
12 | Rajesh Exports | 159 | 122 | 4684 |
13 | Mahindra Life. | 359 | 117 | 5560 |
14 | Astrazeneca Phar | 7104 | 106 | 17759 |
15 | Honasa Consumer | 222 | 106 | 7220 |
16 | The Ramco Cement | 845 | 102 | 19958 |
17 | Suven Pharma | 1090 | 99 | 27739 |
18 | Kaynes Tech | 4008 | 99 | 25658 |
19 | IFCI | 45 | 98 | 11657 |
20 | Amber Enterp. | 5817 | 89 | 19676 |
21 | Radico Khaitan | 2043 | 88 | 27335 |
22 | TBO Tek | 1617 | 82 | 17563 |
23 | Netweb Technol. | 1409 | 79 | 7983 |
24 | GE Vernova T&D | 1475 | 77 | 37762 |
25 | Century Plyboard | 751 | 77 | 16694 |
When one excludes these stocks with PE above 100, the index PE ratio contracts to ~ 26.20, signaling valuations ~ 10% below the historical median average levels.
Market Correction Insights
Let us now look at the price corrections within the Nifty Smallcap 250 Index from their 52-week highs:
Correction Range from 52 Week High | Number of stocks | % of Small cap 250 Index |
Up to 15% Correction | 16 | 6.40% |
15% - 30% Correction | 81 | 32.40% |
30% + Correction | 153 | 61.20% |
Total | 250 | 100% |
This shows that over 60% of the small-cap universe has corrected by 30% or more creating favorable valuations for stocks. However, since the stock market is a forward-looking machine, it is necessary to combine this study with the future earnings growth potential of each stock to make an informed decision.
Conclusion:
Our study shows that valuations are now fair and one should start considering the small cap space for investments in a staggered manner. A few things to keep in mind -
Small-cap investments require patience. A minimum holding period of 5 years is essential to ride out volatility and capture long-term growth.
It is crucial that one does not jump and buy any small cap equity fund simply by looking at past historical returns but rather conduct a thorough study of the constituents of the fund to prevent from investing in under-performing funds.



Comments